Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Video of Gregg Stone, MD, explaining the late-breaking RELIEVE-HF trial he presented at ACC.24 this week. #ACC24 #ACC2024

Inter-atrial shunt in RELIEVE-HF improves symptoms in HFrEF, but not HFpEF

Gregg Stone, MD, explains the details of the late-breaking RELIEVE-HF trial at ACC.24, where an inter-atrial shunt improved symptoms in HFrEF, but not in HFpEF patients.

artificial intelligence in healthcare

AI able to assess invasiveness of lung lesions to aid in surgery

In a study, the most accurate model combined deep-learning with a radionomics approach.

Medicare money payment physician

Critics call out ‘woefully inadequate’ CMS proposal for inpatient Medicare payments

CMS has issued its proposed rule for the 2025 Medicare hospital inpatient prospective payment system, suggesting a payment increase of 2.6%. According to the American Hospital Association, this update would not be enough at a time when hospitals are already struggling to stay open. 

FDA grants new imaging tool for CTO interventions its breakthrough device designation

The new device delivers real-time OCT visualization during revascularization procedures.

Video of Howard Herrmann, MD, explaining the details of the SMART trial that looked at TAVR in small annulus and found self-expanding TAVR valves work better in these patients than balloon-expanding TAVR.

Cardiologist highlights key takeaways from SMART trial, which looked at TAVR in small annulus patients

Howard C. Herrmann, MD, principal investigator of the SMART trial, discussed his team's research on self-expanding vs. balloon-expandable TAVR valves in patients with small annuli. 

doctor examines patient data on their tablet

TAVR, SAVR both linked to low reintervention rates after five years

While most TAVR-related reinterventions occurred in the first year after treatment, most SAVR-related reinterventions occurred in years two through five. The team's full analysis is available in JACC: Cardiovascular Interventions.

First look at data on Biosense Webster Dual Energy THERMOCOOL SMARTTOUCH SF platform for atrial fibrillation presented at EHRA Congress

The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is the first dual energy pulsed field (PF) ablation / radiofrequency (RF) ablation catheter integrated with a PF and RF ablation index.

First-in-human trial shows potential of guiding CABG with cardiac CT and AI—no ICA required

An independent heart team blinded to ICA results was able to deliver helpful guidance for CABG procedures for 99.1% of patients using just CCTA and FFRCT alone. This approach is safe and feasible, researchers wrote, and the next step is to gather additional data. 

Displaying 1145 - 1152 of 6427
Design by Adaptive Theme